期刊名称：DIABETES & VASCULAR DISEASE RESEARCH
|
ISSN： | 1479-1641
|
|
出版频率： | Bi-monthly
|
|
出版社： | SAGE PUBLICATIONS LTD, 1 OLIVERS YARD, 55 CITY ROAD, LONDON, ENGLAND, EC1Y 1SP
|
|
出版社网址： | http://www.uk.sagepub.com
|
|
期刊网址： | http://dvr.sagepub.com/
|
|
影响因子： | 3.291 |
| 主题范畴： | ENDOCRINOLOGY & METABOLISM; PERIPHERAL VASCULAR DISEASE |
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Diabetes and Vascular Disease Research
2012 Impact Factor: 2.594
2012 Ranking: 33/67 in Peripheral Vascular Disease | 63/121 in Endocrinology & Metabolism Source: 2012 Journal Citation Reports ® (Thomson Reuters, 2013)
Diabetes & Vascular Disease Research is the first international peer-reviewed journal to unite diabetes and vascular disease in a single title.
It mirrors the increasing recognition that diabetes and cardiovascular disease are a single entity in which diabetes and related disorders, such as insulin resistance, are directly linked with assaults on the vessel wall and the development of vascular risk clustering.
Diabetes & Vascular Disease Research:
- Links diabetes, its metabolic consequences and vascular outcomes
- Original research in fields of insulin resistance and metabolic disorders
- Promotes understanding of pathology, aetiology and management of thrombosis, hyperglycaemia, hypertension, dyslipidaemia and micro- and macrovascular consequences.
This journal is a member of the Committee on Publication Ethics (COPE).
Aims & Scope
Diabetes & Vascular Disease Research is the first international peer-reviewed journal to unite diabetes and vascular disease in a single title.
It mirrors the increasing recognition that diabetes and cardiovascular disease are a single entity in which diabetes and related disorders, such as insulin resistance, are directly linked with assaults on the vessel wall and the development of vascular risk clustering.
Diabetes & Vascular Disease Research:
- Links diabetes, its metabolic consequences and vascular outcomes
- Original research in fields of insulin resistance and metabolic disorders
- Promotes understanding of pathology, aetiology and management of thrombosis, hyperglycaemia, hypertension, dyslipidaemia and micro- and macrovascular consequences.
Abstracting/indexing
EMBASE/Excerpta Medica
Index Medicus
Index Medicus (Ceased 2004)
MEDLINE
Scopus
Instructions to Authors
Manuscript Submission Guidelines
- Peer review policy
- Article types
2.1 Summary of manuscript structure/style
- How to submit your manuscript
- Journal contributor’s publishing agreement
4.1 SAGE Choice
- Declaration of conflicting interests policy
- Other conventions
6.1 Informed consent
6.2 Ethics
- Acknowledgments
7.1 Funding acknowledgement
- Permissions
- Manuscript style
9.1 File types
9.2 Journal style
9.3 Reference style
9.4 Manuscript preparation
9.4.1 Keywords and abstracts: Helping readers find your article online
9.4.2 Corresponding author contact details
9.4.3 Guidelines for submitting artwork, figures and other graphics
9.4.4 Guidelines for submitting supplemental files
9.4.5 English language editing services
- After acceptance
10.1 Proofs
10.2 E-Prints and complimentary copies
10.3 SAGE production
10.4 OnlineFirst publication
- Further information
The Diabetes & Vascular Disease Research is pleased to consider original papers, reviews, discussions of topical issues, case studies, meeting reports, and other contributions relevant to the understanding, treatment and care of diabetes and vascular disease.
1. Peer review policy
Original papers and reviews are sent for independent peer-review. The Diabetes & Vascular Disease Research operates a single-blind reviewing policy in which the reviewer's name is always concealed from the submitting author, although authors are given the opportunity to suggest reviewers.
Back to top
2. Article types
The journal publishes original papers, reviews, discussions of topical issues, case studies and meeting reports. The journal reproduces photographs in full colour. The suggested word counts only refer to the body of the text and exclude references etc.
2.1 Summary of manuscript structure:
Title page (title of article, author names - forename, initials, surname - author affiliations, author for correspondence - title, address, telephone and fax numbers, email). Sole author articles should be accompanied by a relatively recent photograph of the author (at least 55 mm x 70 mm in size and at a minimum resolution of 300 dpi).
Originals, Reviews, Achieving Best Practice, Current Topics: Abstract < 150 words, max. Key Words 6 max.; Abbreviations and Acronyms box (do not write in full in text); Key Messages 5 max.; Subheaded text, to include an Introduction and Conclusion/Discussion; References (ideally max. 30); Vancouver - <4 authors cite all, >4 authors cite first 3 et al.; Ref title. Journal year,vol:pages. Provide web addresses and month accessed. Tables - ideally submitted in Word. Figures - ideally submitted in PowerPoint using journal colours (pinks/maroon/grey) which can be modified to journal pantones by Production. Font styles should be consistent across all submitted figures. All figures and tables require legends and keys/abbreviations as appropriate. Photographs/Images - original image saved as .tiff or .eps file (minimum resolution 300 dpi), see section 9.4.3 for more details.
Editorials, Case studies - as above but omit Abstract, Key Words and Key Messages.
Manuscripts should be structured as listed below.
Original papers
Should include:
- Title page.
- Abstract (<150 words): a short inclusive statement suitable for direct electronic abstracting identifying the purpose of the study, key methods, the main results and the main conclusion.
- Key words: maximum of 6 key words for indexing.
- Introduction: concise description of background, sufficient for the non-specialist to appreciate the context of the work. Clear statement of the purpose of the study.
- Methods: a brief description of study design, procedures, analytical techniques and statistical evaluation.
- Results: a clear account of the study findings using quantitative language where possible and cross-referenced to tables and figures (ideally in PowerPoint using journal colours).
- Discussion: an interpretation of the study placed within the context of current knowledge leading to specific conclusions where possible.
- Each of the above sections should use subheadings as appropriate
- Acknowledgements.
- References (ideally max. 30), figures and tables (see 9.4.3 for more details).
Reviews, Achieving Best Practice and Current Topics
Should include:
- Title page as above. Abbreviations & Acronyms box as necessary.
- Abstract (<150 words): setting out the scope, key messages and conclusions of the review.
- Body of text: liberally partitioned with headings and subheadings leading to a synopsis with conclusions at the end.
Reviews ~2,500 words; Ach Best Pract 1,000-2,000 words; Curr Top 500-1,500 words
- Key messages: in a separate box itemising 2-5 very short principal points.
- Acknowledgements.
- References (ideally max. 30), figures and tables (see 9.4.3 for more details).
Editorial
Should include:
- Title page as above. Abbreviations & Acronyms box as necessary.
- Body of text: 500-2,500 words, liberally partitioned with headings and subheadings leading to a synopsis with conclusions at the end.
- References (ideally max. 30), figures and tables (see 9.4.3 for more details).
Case Study
- Title page as above. Abbreviations & Acronyms box if necessary - if abbreviations only used once, write in full in text.
- Introduction/case history as appropriate (see published studies). 200-500 words. Succinct Conclusion/Discussion containing the key learning points provided by the case If you are considering a longer Case study please follow all guidance for an Achieving Best Practice article.
- Photograph/Image (original image saved as .tiff or .eps file - minimum resolution of 300 dpi - for scanned photographs see 9.4.3).
- References (ideally max. 5), photographs, figures and tables (see 9.4.3 for more details).
If you would like to discuss your paper prior to submission contact the Editor (p.j.grant@leeds.ac.uk) or Editor’s Assistant (V.L.Harper@leeds.ac.uk).
Back to top
3. How to submit your manuscript
Before submitting your manuscript, please ensure you carefully read and adhere to all the guidelines and instructions to authors provided below. Manuscripts not conforming to these guidelines may be returned.
Diabetes & Vascular Disease Research has a fully web-based system for the submission and review of manuscripts. All submissions should be made online at the Diabetes & Vascular Disease Research SAGETRACK website:
http://mc.manuscriptcentral.com/dvdres
Note: Online submission and review of manuscripts is now mandatory for all types of papers.
New User Account
Please log onto the website. If you are a new user, you will first need to create an account. Follow the instructions and please ensure to enter a current and correct email address. Creating your account is a three-step process that takes a matter of minutes. When you have finished, your User ID and password is sent immediately via email. Please edit your user ID and password to something more memorable by selecting 'edit account' at the top of the screen. If you have already created an account but have forgotten your details type your email address in the 'Password Help' to receive an emailed reminder. Full instructions for uploading the manuscript are provided on the website.
New Submission
Submissions should be made by logging in and selecting the Author Centre and the 'Click here to Submit a New Manuscript' option. Follow the instructions on each page, clicking the 'Next' button on each screen to save your work and advance to the next screen. If at any stage you have any questions or require the user guide, please use the 'Get Help Now' button at the top right of every screen. Further help is available through ScholarOne's® Manuscript CentralTM customer support at +1 434 817 2040 x 167 or email the editor with your manuscript as an attachment(s) and write a note to explain why you need to submit via this route.
To upload your files, click on the 'Browse' button and locate the file on your computer. Select the designation of each file (i.e. main document, submission form, figure) in the drop down menu next to the browse button. When you have selected all the files you wish to upload, click the 'Upload Files' button.
Review your submission (in both PDF and HTML formats) and then click the Submit button
You may suspend a submission at any point before clicking the Submit button and save it to submit later. After submission, you will receive a confirmation e-mail. You can also log back into your author centre at any time to check the status of your manuscript.
Please ensure that you submit editable/source files only (Microsoft Word or RTF) and that your document does not include page numbers; the SAGETRACK system will generate them for you, and then automatically convert your manuscript to PDF for peer review. All correspondence, including notification of the Editor's decision and requests for revisions, will be by email.
If you would like to discuss your paper prior to submission contact the Editor (p.j.grant@leeds.ac.uk) or Editor’s Assistant (V.L.Harper@Leeds.ac.uk).
If you seek advice on the submission process please contact the Publishing Editor: charlotte.jardine@sagepub.co.uk
Back to top
4. Journal contributor’s publishing agreement
Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is a exclusive licence agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and licence to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.
4.1 SAGE Choice
Your article will be freely available online immediately upon publication (as some funding bodies now require; this has been customary for this journal since launch), the manuscript submission and peer reviewing procedure is unchanged. On acceptance of your article, you will be asked to let SAGE know directly if you are choosing SAGE Choice. For further information, please visit SAGE Choice.
Back to top
5. Declaration of conflicting interests
Within your Journal Contributor’s Publishing Agreement you will be required to make a certification with respect to a declaration of conflicting interests. It is the policy of Diabetes & Vascular Disease Research to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please include any declaration at the end of your manuscript after any acknowledgements and prior to the references, under a heading ‘Conflict of Interest Statement’. If no declaration is made, the following will be printed under this heading in your article: ‘None Declared’. Alternatively, you may wish to state that ‘The Author(s) declare(s) that there is no conflict of interest’.
When making a declaration, the disclosure information must be specific and include any financial relationship that all authors of the article have with any sponsoring organization and the for-profit interests that the organisation represents, and with any for-profit product discussed or implied in the text of the article.
Any commercial or financial involvements that might represent an appearance of a conflict of interest need to be additionally disclosed in the covering letter accompanying your article to assist the Editor in evaluating whether sufficient disclosure has been made within the Conflict of Interest statement provided in the article.
For more information please visit the SAGE Journal Author Gateway.
Back to top
6. Other conventions
6.1 Informed consent
Authors are required to ensure that the following guidelines are followed, as recommended by the International Committee of Medical Journal Editors ("Uniform Requirements for Manuscripts Submitted to Biomedical Journals": http://www.icmje.org/urm_full.pdf).
Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published.
Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.
When informed consent has been obtained it should be indicated in the submitted article.
Authors should identify individuals who provide writing/administrative assistance, indicate the extent of assistanceand disclose the funding source for this assistance.
Identifying details should be omitted if they are not essential.
6.2 Ethics
When reporting experiments on human subjects, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) or with the Declaration of Helsinki 1975, revised Hong Kong 1989. Do not use patients' names, initials or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate which guideline/law on the care and use of laboratory animals was followed.
Back to top
7. Acknowledgements
Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.
All contributors who do not meet the criteria for authorship should be listed in an `Acknowledgements’ section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support. Authors should disclose whether they had any writing assistance and identify the entity that paid for this assistance.
7.1 Funding Acknowledgement
To comply with the guidance for Research Funders, Authors and Publishers issued by the Research Information Network (RIN), Diabetes & Vascular Disease Research additionally requires all Authors to acknowledge their funding in a consistent fashion under a separate heading. All research articles should have a funding acknowledgement in the form of a sentence as follows, with the funding agency written out in full, followed by the grant number in square brackets:
This work was supported by the Medical Research Council [grant number xxx].
Multiple grant numbers should be separated by comma and space. Where the research was supported by more than one agency, the different agencies should be separated by semi-colons, with “and” before the final funder. Thus:
This work was supported by the Wellcome Trust [grant numbers xxxx, yyyy]; the Natural Environment Research Council [grant number zzzz]; and the Economic and Social Research Council [grant number aaaa].
In some cases, research is not funded by a specific project grant, but rather from the block grant and other resources available to a university, college or other research institution. Where no specific funding has been provided for the research we ask that corresponding authors use the following sentence:
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Please include this information under a separate heading entitled “Funding” directly after any other Acknowledgements prior to your “Declaration of Conflicting Interests” (if applicable), any Notes and your References.
For more information on the guidance for Research Funders, Authors and Publishers, please visit: http://www.rin.ac.uk/funders-acknowledgement.
Back to top
8. Permissions
Authors are responsible for obtaining permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.
Back to top
9. Manuscript style
9.1 File types
Only electronic files conforming to the journal's guidelines will be accepted. Preferred formats for the text and tables of your manuscript are Word DOC, and tiff or jpeg for figures. Please also refer to additional guideline on submitting artwork [and supplemental files] below
9.2 Journal Style
Diabetes & Vascular Disease Research conforms to the SAGE house style. Click here to review guidelines on SAGE UK House Style, which is summarised in 2.1.
9.3 Reference Style
Diabetes & Vascular Disease Research adheres to the SAGE Vancouver reference style. Click here to review the guidelines on SAGE Vancouver to ensure your manuscript conforms to this reference style.
9.4. Manuscript Preparation
The text should be double-spaced throughout and with a minimum of 3cm for left and right hand margins and 5cm at head and foot. Text should be standard 10 or 12 point.
9.4.1 Keywords and Abstracts: Helping readers find your article online
The title, keywords and abstract are key to ensuring that readers find your article online through online search engines such as Google. Please refer to the information and guidance on how best to title your article, write your abstract and select your keywords by visiting SAGE’s Journal Author Gateway Guidelines on How to Help Readers Find Your Article Online.
9.4.2 Corresponding Author Contact details
Provide full contact details for the corresponding author including email, mailing address and telephone numbers. Academic affiliations are required for all co-authors.
9.4.3 Guidelines for submitting artwork, figures and other graphics
For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines.
Images should be supplied as bitmap based files (i.e. with .tiff or .jpeg extension) with a resolution of at least 300 dpi (dots per inch). Line art should be supplied as vector-based, separate .eps files (not as .tiff files, and not only inserted in the Word or pdf file), with a resolution of 600 dpi. Images should be clear, legible, in focus, free of pixilation and not too light or dark.
If, together with your accepted article, you submit usable colour figures, these figures will appear in colour online regardless of whether or not these illustrations are reproduced in colour in the printed version. For specifically requested colour reproduction in print, you will receive information regarding the possible costs from SAGE after receipt of your accepted article.
In text: tables and figures are either inserted as part of a sentence, for example table 1 or in parentheses for example (figure 1). Each table should carry a descriptive heading. Each figure should be submitted electronically.
Any artwork provided should be in .tiff format. Each piece of artwork should be saved as a separate file. No artwork should be included in the text files. Revised manuscripts should be resubmitted as executable files only, i.e. MS Word.
Illustrations: Computer generated graphics. All art that must be sent electronically in .eps or .tiff files, at 300 dpi resolution, for superior reproduction. Please indicate the position of all figures in the text. When graphs or histograms are submitted the numerical data on which they are based should be supplied.
Line drawings: Originals should always be submitted. Wherever possible, graphs should be boxed in, and scale divisions should be marked on the inside of the boxes. Grids should not be shown. Insofar as possible, explanations should be placed in the legend. Original drawings should not be larger than 20 25 cm (8 10 in). Lettering should be planned for 50% reduction; text must be readable after reduction. Text must be readable after reduction.
Photographs: All photographs should be in a high quality digital format of at least 300 dpi resolution. Patients in photographs should not be identifiable and should have their eyes masked. Any identifiable photograph should be accompanied by written permission from the patient, parent or guardian. Photographs will only be printed in colour if the author bears the cost of reproduction, however if colour photographs are supplied they will appear as such online.
Tables: Indicate in the margin of the text where tables should be positioned. Each table should have an explanatory caption, and be clearly numbered.
9.4.4 Guidelines for submitting supplemental files
The journal may be able to host approved supplemental materials online, alongside the full-text of articles. Supplemental files will be subjected to peer-review alongside the article. Please contact the Editor (p.j.grant@leeds.ac.uk) or Editor’s Assistant (n.j.houseman@leeds.ac.uk) in the first instance. For more information please refer to SAGE’s Guidelines for Authors on Supplemental Files.
9.4.5 English Language Editing services
Non-English speaking authors who would like to refine their use of language in their manuscripts should have their manuscript reviewed by colleagues with experience of preparing manuscripts in English.
Alternatively it might be useful to consider using a professional editing service. Visit http://www.uk.sagepub.com/journalgateway/msg.htm for further information.
Back to top
10. After acceptance
10.1 Proofs
We will email a PDF of the proofs to the corresponding author. Corrections should be limited to typographical amendments. Authors' approval will be assumed if corrections are not returned by the date indicated.
10.2 E-Prints and Complimentary Copies
SAGE provides authors with access to a PDF of their final article. For further information please visit Offprints and Reprints.
10.3 SAGE Production
At SAGE we place an extremely strong emphasis on the highest production standards possible. We attach high importance to our quality service levels in copy-editing, typesetting, printing, and online publication ( http://online.sagepub.com/ ). We also seek to uphold excellent author relations throughout the publication process.
We value your feedback to ensure that we continue to improve our author service levels. On publication all corresponding Authors will receive a brief survey questionnaire on your experience of publishing in Diabetes & Vascular Disease Research with SAGE.
10.4 OnlineFirst Publication
Diabetes & Vascular Disease Research provides the opportunity for your article to be included in OnlineFirst, a feature offered through SAGE’s electronic journal platform, SAGE Journals Online. It allows final revision articles (completed articles in queue for assignment to an upcoming issue) to be hosted online prior to their inclusion in a final print and online journal issue. This significantly reduces the lead time between submission and publication. For more information please visit our OnlineFirst Fact Sheet.
Back to top
11. Further information
Charlotte Jardine
Publishing Editor
SAGE Publications
1 Oliver's Yard
55 City Road
London
EC1Y 1SP
charlotte.jardine@sagepub.co.uk
+44 (0)20 7336 1244
Back to top
Editorial Board
Editor In Chief:
Diabetes Editor:
Vascular Disease Editor:
University of Aachen, Germany
Clinical Trials Editor:
University of Texas Southwestern Medical Centre, USA
Pre-clinical Research Editor:
Baker IDI Heart and Diabetes Institute, Australia
Assistant Editors:
University of Pisa, Italy
Yale University School of Medicine, USA
National Institute of Diabetes and Digestive and Kidney Diseases, AZ, USA
Oxford Centre for Diabetes, Endocrinology & Metabolism, UK
Associate Editor:
Editorial Assistant:
Leeds University, UK
Editorial Board:
| Lina Badimon |
Hospital de la Santa Creu I Sant Pau, Barcelona, Spain |
| Odette Gore |
University of Texas Southwestern Medical Center, USA |
| Bruce Neal |
The George Institute for Global Health, Australia |
| Bart Staels |
Universiti Lille Nord de France Institut Pasteur de Lille, France |
| E Standl |
Diabetes Research Institute, Munich, Germany |
|
